Cutler Group LP Abbott Laboratories Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

23 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $2.15 Million - $2.37 Million	-19,600 Reduced 91.16%	1,900 $56,000
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $2.48 Million - $3.04 Million	-27,500 Reduced 56.12%	21,500 $143,000
Q3 2023 Nov 07, 2023	BUY	$95.53 - $114.62 $1.98 Million - $2.37 Million	20,700 Added 73.14%	49,000 $64,000
Q2 2023 Jul 18, 2023	BUY	$100.78 - $112.29 $1.25 Million - $1.39 Million	12,400 Added 77.99%	28,300 $91,000
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $4.63 Million - $5.45 Million	-47,800 Reduced 75.04%	15,900 $13,000
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $608,384 - $713,728	6,400 Added 11.17%	63,700 $89,000
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $454,772 - $526,541	4,700 Added 8.94%	57,300 $39,000
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $7.82 Million - $9.45 Million	-76,600 Reduced 59.29%	52,600 $56,000
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $13.3 Million - $16.2 Million	116,700 Added 933.6%	129,200 $296,000
Q4 2021 Jan 18, 2022	BUY	$115.53 - $141.46 $150,189 - $183,898	1,300 Added 11.61%	12,500 $99,000
Q3 2021 Oct 26, 2021	BUY	$116.66 - $129.06 $478,306 - $529,146	4,100 Added 57.75%	11,200 $43,000
Q2 2021 Jul 19, 2021	BUY	$105.79 - $124.53 $751,109 - $884,163	7,100 New	7,100 $16,000
Q1 2021 Apr 26, 2021	SELL	$108.84 - $128.23 $413,592 - $487,273	-3,800 Closed	0 $0
Q4 2020 Jan 21, 2021	SELL	$105.0 - $114.42 $73,500 - $80,094	-700 Reduced 15.56%	3,800 $3,000
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $76,570 - $98,000	-1,000 Reduced 18.18%	4,500 $5,000
Q2 2019 Aug 09, 2019	SELL	$72.88 - $85.0 $2.21 Million - $2.58 Million	-30,300 Reduced 84.64%	5,500 $160,000
Q1 2019 May 10, 2019	BUY	$66.22 - $80.06 $1.48 Million - $1.79 Million	22,400 Added 167.16%	35,800 $175,000
Q4 2018 Feb 05, 2019	SELL	$65.56 - $74.27 $1.09 Million - $1.23 Million	-16,600 Reduced 55.33%	13,400 $271,000
Q3 2018 Nov 07, 2018	SELL	$60.81 - $73.36 $291,888 - $352,128	-4,800 Reduced 13.79%	30,000 $319,000
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $1.09 Million - $1.21 Million	19,000 Added 120.25%	34,800 $110,000
Q1 2018 May 11, 2018	SELL	$56.27 - $63.62 $849,677 - $960,662	-15,100 Reduced 48.87%	15,800 $104,000
Q4 2017 Jan 17, 2018	SELL	$53.68 - $57.47 $311,344 - $333,326	-5,800 Reduced 15.8%	30,900 $116,000
Q3 2017 Oct 17, 2017	BUY	$48.06 - $53.64 $1.76 Million - $1.97 Million	36,700	36,700 $146,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.2 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$8.76 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.51 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.09 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account